These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3754387)

  • 1. Sequential nonstress testing with use of each fetus as its own control.
    Devoe LD; Castillo R; McKenzie J; Searle N; Robinson B; Davis H
    Am J Obstet Gynecol; 1986 Apr; 154(4):931-6. PubMed ID: 3754387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percent acceleration time: a new method of fetal assessment.
    Devoe LD; Castillo R; Saad S; McKenzie J; Searle N; Davis H
    Obstet Gynecol; 1986 Feb; 67(2):191-6. PubMed ID: 3945428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonstress test: dimensions of normal reactivity.
    Devoe LD; McKenzie J; Searle N; Sherline DM
    Obstet Gynecol; 1985 Nov; 66(5):617-20. PubMed ID: 4058819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antepartum nonstress fetal heart rate monitoring: systematic analysis of baseline patterns and decelerations as an adjunct to reactivity in the prediction of fetal risks.
    Brioschi PA; Extermann P; Terracina D; Weil C; Mao WT; Beguin F
    Am J Obstet Gynecol; 1985 Nov; 153(6):633-7. PubMed ID: 4061531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective analysis of the influence of gestational age on the baseline fetal heart rate and reactivity in a low-risk population.
    Smith CV; Phelan JP; Paul RH
    Am J Obstet Gynecol; 1985 Dec; 153(7):780-2. PubMed ID: 4073143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal interventions based upon fetal surveillance of the daily opioid-exposed fetus: a descriptive analysis.
    Brar B; Jackson D; Nat M; Patil P; Iriye B; Planinic P
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):909-912. PubMed ID: 30078349
    [No Abstract]   [Full Text] [Related]  

  • 7. The association between fetal heart rate patterns and fetal movements in pregnancies between 20 and 30 weeks' gestation.
    Sorokin Y; Dierker LJ; Pillay SK; Zador IE; Schreiner ML; Rosen MG
    Am J Obstet Gynecol; 1982 Jun; 143(3):243-9. PubMed ID: 7081342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of nonstress test from 24 to 42 weeks' gestation.
    Sato A; Chin E; Endo C; Kyozuka M; Akagi K; Saito J; Yamaguchi Y; Sato M; Liou S; Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2634-40. PubMed ID: 6520485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new modality in nonstress testing: evaluation of beat-to-beat fetal heart rate variability.
    Lauersen NH; Wilson KH; Bilek A; Rao VS; Kurkulos M
    Am J Obstet Gynecol; 1981 Nov; 141(5):521-6. PubMed ID: 7294079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of fetal heart rate decelerations during nonstress testing.
    Bourgeois FJ; Thiagarajah S; Harbert GM
    Am J Obstet Gynecol; 1984 Sep; 150(2):213-6. PubMed ID: 6476042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing role of the nonstress test in the management of postdates pregnancy.
    Phelan JP; Platt LD; Yeh SY; Trujillo M; Paul RH
    Obstet Gynecol; 1984 Nov; 64(5):624-8. PubMed ID: 6493655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preterm nonstress testing: 10-beat compared with 15-beat criteria.
    Glantz JC; Bertoia N
    Obstet Gynecol; 2011 Jul; 118(1):87-93. PubMed ID: 21691167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of maternal cocaine use on the fetus: changes in antepartum fetal heart rate tracings.
    Tabor BL; Soffici AR; Smith-Wallace T; Yonekura ML
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1278-81. PubMed ID: 1957845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic components of the nonreactive nonstress test.
    Ingardia CJ; Cetrulo CL; Knuppel RA; Kappy KA; Scerbo JC; Lake M; Aumann G
    Obstet Gynecol; 1980 Sep; 56(3):305-10. PubMed ID: 7422169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nonstress test: the value of a single acceleration in evaluating the fetus at risk.
    Mendenhall HW; O'Leary JA; Phillips KO
    Am J Obstet Gynecol; 1980 Jan; 136(1):87-91. PubMed ID: 7352492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of spontaneous fetal heart rate decelerations during antepartum nonstress testing and intrauterine growth retardation.
    Pazos R; Vuolo K; Aladjem S; Lueck J; Anderson C
    Am J Obstet Gynecol; 1982 Nov; 144(5):574-7. PubMed ID: 7137243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical sequelae of the extended nonstress test.
    Devoe LD; McKenzie J; Searle NS; Sherline DM
    Am J Obstet Gynecol; 1985 Apr; 151(8):1074-8. PubMed ID: 3985067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal heart rate acceleration: fetal movement ratio in the management of high-risk pregnancy.
    Arias JW; Saldana LR; Rivera-Alsina M; Ali V
    Obstet Gynecol; 1982 Oct; 60(4):427-30. PubMed ID: 7121928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable decelerations during nonstress tests are not a sign of fetal compromise.
    Meis PJ; Ureda JR; Swain M; Kelly RT; Penry M; Sharp P
    Am J Obstet Gynecol; 1986 Mar; 154(3):586-90. PubMed ID: 3953704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcome in the patient with a nonreactive nonstress test and a positive contraction stress test.
    Slomka C; Phelan JP
    Am J Obstet Gynecol; 1981 Jan; 139(1):11-5. PubMed ID: 7457512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.